AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 295: F843-F850, 2008. First published July 23, 2008; doi:10.1152/ajprenal.90348.2008
0363-6127/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/3/F843    most recent
90348.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Pearce, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Pearce, D.

Activity of the p110-{alpha} subunit of phosphatidylinositol-3-kinase is required for activation of epithelial sodium transport

Jian Wang,1,2 Zachary A. Knight,2 Dorothea Fiedler,2 Olusegun Williams,2 Kevan M. Shokat,2 and David Pearce1,2

1Division of Nephrology, Department of Medicine, San Francisco General Hospital, and 2Department of Cellular and Molecular Pharmacology, University of California, San Francisco, California

Submitted 5 June 2008 ; accepted in final form 17 July 2008

The pathways implicated in the control of epithelial Na+ channel (ENaC)-dependent Na+ transport in renal collecting duct cells share substantial parallels with those implicated in insulin-regulated glucose metabolism. Notably, both are inhibited by wortmannin and LY294002 and signal through phosphatidylinositol-3-kinase (PI3K)-dependent kinases SGK1 and Akt. The inhibitor pattern is thought to reflect dependence on PI3K activity since wortmannin and LY294002 are both effective inhibitors of this kinase. However, these inhibitors block a variety of kinases from different families and lack specificity within the PI3K family. To begin to dissect more precisely the pathways required for signaling and for control of Na+ transport in renal collecting duct cells, we have examined the effect of a set of PI3K inhibitors, which selectively block distinct subsets of PI3K catalytic subunit isoforms. We have found that ENaC-dependent Na+ transport was blocked by inhibitors of the p110-{alpha} isoform of PI3K, but not by inhibitors of p110-β, -{gamma}, or -{delta}. Inhibitors that block Na+ current also blocked SGK1 and Akt phosphorylation. In contrast to insulin-stimulated glucose uptake in muscle cells, p110-β inhibition did not enhance sensitivity to p110-{alpha} inhibition. These data support the conclusion that ENaC-dependent Na+ current is controlled exclusively by p110-{alpha}, the same isoform that is the principal mediator of insulin effects on glucose metabolism, and lacks any dependence on p110-β. These findings further underscore the extent to which Na+ and glucose regulation are intertwined and provide additional insight into the interconnections between diabetes and hypertension.

phosphoinositide; sgk; phosphatidylinositol-3-phosphokinase; insulin; aldosterone



Address for reprint requests and other correspondence: D. Pearce, Div. of Nephrology, Dept. of Medicine, San Francisco General Hospital, 1001 Potrero Ave., Bldg. 100, Rm. 342, San Francisco, CA 94110 (e-mail: dpearce{at}medsfgh.ucsf.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.